Table 3.
Para-SCI (n = 35) | Tetra-SCI (n = 12) | Mean Difference | 95% CI of the Difference | Percent Difference Between Groups | Able-bodied normal values55 | |
---|---|---|---|---|---|---|
Tumor necrosis factor-α (pg/ml) | 8.70 ± 0.75 | 8.92 ± 0.97 | −0.22 | −0.76, 0.33 | 2.50% | 0.65–1.84 |
Interleukin-6 (pg/ml) | 4.57 ± 3.56 | 11.3 ±17.62* | 16.64 | −12.96, −0.5 | 84.81% | 0.26–0.82 |
Plasminogen activator inhibitor-1 (ng/mL) | 68.38 ± 62.08 | 51.73 ± 32.48 | 16.64 | −21.36, 54.65 | 141.43% | Not Applicable |
Thrombin activatable fibrinolysis inhibitor-1 (ng/ml) | 9.86 ± 1.91 | 9.76 ± 2.99 | 0.10 | −1.39, 1.6 | 1.02% | Not Applicable |
High-sensitivity c-reactive protein (mg/L) | 7.08 ± 6.51 | 8.41 ± 7.99 | −1.32 | −5.97, 3.33 | 17.17% | 1.65–2.17 |
Note: CI, 95% confidence internal; Able-bodied normal values adapted from Wyczalkowska-Tomasik et al.55
* Significantly different between paraplegia and tetraplegia (p < 0.05).